Canada markets closed

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
13.28-0.66 (-4.73%)
At close: 04:00PM EDT
13.39 +0.11 (+0.83%)
After hours: 05:18PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 838.94M
Enterprise Value 125.23M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.18
Price/Book (mrq)1.19
Enterprise Value/Revenue 1.38
Enterprise Value/EBITDA -0.25

Trading Information

Stock Price History

Beta (5Y Monthly) 0.85
52-Week Change 3-72.40%
S&P500 52-Week Change 323.57%
52 Week High 359.99
52 Week Low 310.92
50-Day Moving Average 318.10
200-Day Moving Average 321.74

Share Statistics

Avg Vol (3 month) 31.07M
Avg Vol (10 day) 31.32M
Shares Outstanding 560.18M
Implied Shares Outstanding 660.11M
Float 847.63M
% Held by Insiders 112.47%
% Held by Institutions 196.06%
Shares Short (Apr 15, 2024) 49.31M
Short Ratio (Apr 15, 2024) 411.22
Short % of Float (Apr 15, 2024) 423.37%
Short % of Shares Outstanding (Apr 15, 2024) 415.49%
Shares Short (prior month Mar 15, 2024) 48.4M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,489.18%

Management Effectiveness

Return on Assets (ttm)-31.98%
Return on Equity (ttm)-54.72%

Income Statement

Revenue (ttm)91.06M
Revenue Per Share (ttm)1.52
Quarterly Revenue Growth (yoy)139.90%
Gross Profit (ttm)N/A
EBITDA -507.26M
Net Income Avi to Common (ttm)-503.14M
Diluted EPS (ttm)-8.39
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)717.01M
Total Cash Per Share (mrq)11.91
Total Debt (mrq)3.31M
Total Debt/Equity (mrq)0.47%
Current Ratio (mrq)12.22
Book Value Per Share (mrq)11.73

Cash Flow Statement

Operating Cash Flow (ttm)-424.74M
Levered Free Cash Flow (ttm)-232.9M